Pressure Bio Gets $1.2M from Exercise of Warrants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has raised $1.2 million from the exercise of preferred stock purchase warrants.

The firm said that 98,372 15-month preferred stock purchase warrants were exercised, representing 100 percent of all outstanding and unexercised 15-month warrants that could be exercised after the March 30, 2010 warrant call.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.